Feeds:
Posts
Comments

Posts Tagged ‘Amgen Inc.’

REUTERS: The US Food and Drug Administration has approved the sale of Amgen Inc’s osteoporosis drug Prolia – denosumab – to help prevent fractures in advanced cancer patients just days after the medicine received European approval. It will cost $US825 per 60 milligram injection. READ MORE>

Read Full Post »

MAY 19: PROSTABLOG NZ:  Someone’s making a lot of money from prostate cancer sufferers, as a report analysing world-wide markets for prostate cancer therapeutics (mostly hormonal therapies) – including 138 companies – shows. READ MORE>

Read Full Post »